TCD
Age related macular degeneration (AMD) is the leading cause of irreversible central blindness in the world and certain forms such as geographic atrophy (GA) are untreatable. The aim of this research is to develop a novel therapeutic approach , based on gene therapy for the treatment of AMD and other neurological conditions.
Last Updated:
Last Updated:
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
